Tenilsetam
Alternative Names: CAS 997Latest Information Update: 04 Jul 2007
At a glance
- Originator Cassella
- Class Analgesics; Neuroprotectants
- Mechanism of Action Advanced glycosylation end product inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Dementia; Diabetic retinopathy
Most Recent Events
- 09 May 2001 Tenilsetam is being investigated for use in the prevention of diabetic retinopahy
- 09 May 2001 Preclinical development for Diabetic retinopathy in Germany (unspecified route)
- 22 Jan 1997 Discontinued-Clinical for Dementia in Germany (unspecified route)